Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
immune system
Research
GSK and Cambridge scientists join forces in $65M immune R&D deal
The partners will focus on mechanisms of disease onset, disease progression, patient response to therapies and developing translational biomarkers.
Darren Incorvaia
Oct 22, 2024 3:30pm
BMS pays $65M to expand Repertoire of autoimmune assets
Apr 29, 2024 6:15am
New cell discovery could repair damaged salivary and tear glands
Apr 18, 2022 8:25am
Adaptive Biotechnologies lays off 12% of workforce
Mar 9, 2022 12:02pm
New CRISPR tool maps out routes to better immune cell therapies
Feb 8, 2022 8:25am
Immunai adds $215M to bank to help discovery drug targets
Oct 27, 2021 12:00pm
